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Crystal structure of the ternary complex of 1,3,8-trihydroxy-
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NADPH and an active-site inhibitor
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Background: The enzyme 1,3,8-trihydroxynaphthalene reductase (THNR)
catalyzes an essential reaction in the biosynthesis of melanin, a black pigment
crucial for the pathogenesis of the rice blast fungus, Magnaporthe grisea. The
enzyme is the biochemical target of several commercially important fungicides
which are used to prevent blast disease in rice plants. We have determined the
structure of the ternary complex of THNR with bound NADPH and a fungicide,
tricyclazole.
Results: Crystallographic analysis showed four identical subunits of THNR to
form a tetramer with 222 symmetry. The enzyme subunit consists of a single
domain comprising a seven-stranded b sheet flanked by eight a helices; the
subunit contains a dinucleotide-binding fold which binds the coenzyme, NADPH.
Tricyclazole, an inhibitor of the enzyme, binds at the active site in the vicinity of
the NADPH nicotinamide ring. The active site contains a Ser-Tyr-Lys triad which
is proposed to participate in catalysis. Coenzyme specificity is partly conferred
by the interaction of a single basic residue, Arg39, with the 2′ phosphate group
of NADPH.
Conclusions: The structural model reveals THNR to belong to the family of
short chain dehydrogenases. Despite the diversity of the chemical reactions
catalyzed by this family of enzymes, their tertiary structures are very similar. In
particular THNR has many amino acid sequence identities, and thus most
probably high structural similarities, to enzymes involved in fungal aflatoxin
synthesis. The structure of THNR in complex with NADPH and tricyclazole
provides new insights into the structural basis of inhibitor binding. This new
information may aid in the design of new inhibitors for rice crop protection.
Introduction
The pathogenic fungus Magnaporthe grisea, preys upon the
leaves of rice plants ultimately causing blast disease,
arguably the most destructive disease in crop plants world-
wide. In an intriguing and well documented mechanism,
the pathogen gains access to the cells in the leaf by forced
entry, employing a high-pressured, hole punching machin-
ery [1]. In the initial stages of infection airborne spores of
M. grisea land on the leaf surface and germinate to produce
conidia. Conidia become attached to the epidermal cells of
leaves and develop specialized infection cells known as
appressoria. A layer of fungal melanin is deposited
between the plasma membrane and the cell wall of the
appressorium and this layer serves as a strong and selec-
tive barrier preventing solutes from escaping while per-
mitting water to enter. Hydrostatic pressure increases
within this structure and when it becomes sufficiently
powerful a portion of the appressorium is driven into the
plant cell giving rise to the so called penetration peg and
providing a rich source of nutrients for the voracious
pathogen.
Non-pathogenic M. grisea mutants incapable of producing
melanin have been isolated and characterized [2]. These
mutants were classified into three different phenotypes,
each corresponding to defects on single genes encoding
enzymes essential for the biosynthesis of melanin. One of
these genes encodes the enzyme 1,3,8-trihydroxynaphtha-
lene reductase (THNR). This enzyme is also the target of
fungicides, such as tricyclazole, which are used to control
rice blast disease.
The biosynthesis of melanin in M. grisea starts from
acetate which is converted into melanin in a series of steps
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(Fig. 1a). Biosynthesis proceeds via a pentaketide inter-
mediate that is cyclized into 1,3,6,8-tetrahydroxynaphtha-
lene. In a series of reduction and dehydration reactions
the latter is converted into 1,8-dihydroxynaphthalene
which polymerizes into melanin [3].
We have initiated a structural characterization of the
enzymes in this pathway of melanin biosynthesis and have
previously reported the crystal structure of scytalone
dehydratase [4]. This paper reports on the structure deter-
mination to 2.8 Å resolution of another enzyme in this
pathway, THNR complexed with NADPH and the
inhibitor tricyclazole (Fig. 1b).
Results and discussion
Structure determination and quality of the model
The structure of the THNR–NADPH–tricyclazole ternary
complex was determined by multiple isomorphous replace-
ment using two mercury derivatives. Figure 2 displays a
section from the initial and final electron-density maps.
The refined model includes 270 of the 283 amino acid
residues; electron density for the first 13 residues of the
polypeptide chain is missing. Except for the side chains of
the residues Glu65, Glu68, Glu228, Asn229 and Glu233,
located at the surface of the protein, all side chains were
fitted into the electron density.
The model has been refined using all data between 8.0
and 2.8 Å to a crystallographic R factor of 22.3 %
(Rfree = 25.4 %). The model has good stereochemistry,
reflected in the root mean square (rms) deviation from
standard values for bond lengths of 0.009 Å and angles of
1.5°; 89.0 % of all non-glycine residues have their (f,ψ)
angles in the most favored region of the Ramachandran
plot. The positions of the six heavy-atom ions were
confirmed by a difference Fourier map, calculated with
phases from the protein model after the crystallographic
refinement was concluded. All mercury ions in the 
two heavy-atom derivatives bind to cysteine residues,
and the three heavy metal binding sites in the subunit
are formed by residues Cys83, Cys191 and Cys282,
respectively.
Overall structure of the subunit
The THNR subunit is composed of one domain, with
dimensions 35 × 50 × 30 Å. The subunit contains seven
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Figure 1
(a) Biosynthesis of melanin in Magnaporthe
grisea; (b) the inhibitor tricyclazole.
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Figure 2
Electron-density maps for the THNR–NADPH–
tricyclazole structure. (a) Part of the initial
electron-density map at 3.5Å resolution,
contoured at approximately 1s, calculated with
phases refined by twofold non-crystallographic
symmetry averaging using the program DM
[27]. (b) Part of the final 2|Fo|–|Fc| electron-
density map at 2.8Å resolution, contoured at
1s, calculated with phases from the refined
model of THNR–NADPH–tricyclazole. Atoms
are shown in standard colours. (Figure
generated with the program MOLSCRIPT [33]
and rendered using Raster 3D [34].)
b strands, forming a parallel b sheet, eight a helices and a
number of loops of varying length. Flanking the parallel
b sheet on one side are a helices D, E and F and on the
other side a helices C, B and G (Fig. 3). The short a
helix, a2, is positioned nearly perpendicular to the
b sheet, at its top edge (Fig. 4a). The subunit structure
contains the ‘Rossmann fold’ (Fig. 4b), comprising
strands bA–bF, often found in dinucleotide-binding
enzymes [5].
During catalysis, the substrate and coenzyme need to
access the catalytic site, which is buried below the
a1–loop–a2 region. These two helices are stabilized by
interhelical hydrogen bonds. The first multiple hydrogen
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Figure 3
Stereo view of the Ca backbone trace of
THNR. Every twentieth amino acid is
numbered; the N and C termini are marked.
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The overall fold of the THNR subunit. (a) Ribbon diagram of the THNR
subunit; a helices are shown in red, b strands in green and loops in
yellow. Bound NADPH and inhibitor are shown as ball-and-stick
models; atoms are in standard colours. (Figure generated with the
program MOLSCRIPT [33] and rendered with the program Raster3D
[34].) (b) Folding diagram of THNR. Secondary structure elements are
colored as in (a); the blue sphere represents the NADPH-binding site.
The nomenclature for the secondary structure elements was adopted
from [14].
bond is formed between Lys212 and Tyr216, from a1, and
Asp236 from a2. Another hydrogen bond is formed from
the side chain of Arg221, in a1, to the peptide oxygens of
Leu230 and Asn232, in a2.
Quaternary structure
In solution, native THNR subunits assemble into a
homotetramer [6]. In the crystal asymmetric unit, two sub-
units of the tetramer are related by a local twofold symme-
try axis. The tetrameric molecule is generated from this
dimer by the crystallographic twofold symmetry. The size
of the tetramer is 65×70×80Å and each subunit makes
contacts with two neighboring subunits (Fig. 5). Each indi-
vidual subunit has a solvent-accessible surface of 12900Å2
whereas the tetramer has a solvent accessible surface of
35300Å2. Therefore, upon tetramer formation, approxi-
mately 4000Å2 of the solvent-accessible surface is buried
per subunit. The tetramer displays 222 symmetry with two
different interfaces between subunits about three orthogo-
nal molecular axes, called P, Q and R [7], where the Q axis
corresponds to the crystallographic twofold axis.
Throughout the following description the subunits are
numbered 1, 2, 3 and 4 (Fig. 5). Contacts across the P axis
are between subunits 1 and 2 (and between 3 and 4),
contacts across the R axis are between subunits 1 and 3 
(2 and 4) and contacts across the Q axis between subunits 1
and 4 (2 and 3).
The interface between subunit 1 and 2 is formed by con-
tacts between aG1 and aG2 in the form of Phe2611–
Phe2612 stacking and an Asp2661–Arg522 salt bridge.
Closer to the center of the tetramer, the two b sheets are
positioned antiparallel to each other and form a bowl-
shaped 14-stranded b sheet. At the interface close to bG1
and bG2, a salt bridge is formed between Asp2781 and
Lys2732. Between the two interacting a helices and the
b sheet there is a large hydrophobic region spanning both
subunits. In the monomer, several hydrophobic residues
would be exposed to solvent if the P axis interface did not
exist. Also noticeable in the interface is the deeply buried
Trp269, positioned in a pocket of the second subunit close
to the C-terminal end of bG and the loop connecting a2–
aG, thereby anchoring the two subunits together. In total,
2000Å2 of solvent-accessible surface is buried per subunit
in this interface.
There are few interactions between subunits 1 and 3 across
the R axis. In both heavy-metal derivatives, two symmetry
related cysteines from the two subunits (Cys2821 and
Cys2823) each bind a mercury ion, located on the R axis, at
this interface region.
A four-helix bundle consisting of helices aE1 and aF1 and
their corresponding symmetry equivalents, aE4 and aF4
form the interface across the Q axis. A number of hydro-
phobic interactions are found in this interface area, involv-
ing Phe1311, Phe1351, Phe1431, Phe1441 and Phe1881
together with their symmetry counterparts. In addition, two
salt bridges, Arg1401–Asp1324 and Asp1981–His1224, are
present. In total, 1700Å2 of solvent-accessible surface is
buried per subunit in this interface.
NADPH binding
The dinucleotide, NADPH, in the enzyme complex has an
extended conformation, and binds at the C-terminal side of
the parallel b sheet. Figure 6 shows part of the 2|Fo|–|Fc|
electron-density map at the cofactor- and inhibitor-binding
sites, and Figure 7 gives a schematic diagram of the inter-
actions of NADPH with the enzyme. The nicotinamide
ring of NADPH is buried in the protein interior, close to
the loop bF–a1 and not accessible to the bulk solvent. The
nicotinamide mononucleotide ribose moiety has the C2′-
endo conformation and is located between b strands bD
and bE. The adenosine part is positioned in a pocket made
up of b strands bB, bC and bD; the ribose ring adopts the
C2′-endo conformation, and is bound at the switch point of
the b sheet [8] between the C-terminal ends of strands bA
and bD.
The adenine ring binds in a pocket formed by side chains
Ala61, Asn87, Val88, Ser115 and Ile137. Hydrogen bonds
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Figure 5
Tetramer of THNR. Tetramer packing where subunits are numbered 1
(yellow), 2 (red), 3 (green) and 4 (blue). Each subunit contains a ball-
and-stick representation of NADPH and the inhibitor; atoms are shown
in standard colors. (Figure generated with MOLSCRIPT [33] and
rendered with Raster3D [34].)
are formed between N1 of the adenine ring and the
peptide nitrogen of Val88 and also between N3 and the
side chain of Ser115. One oxygen atom of the 2′ ribose
phosphate group forms hydrogen bonds to the peptide
NH groups of Ala61, Asn62 and Ser63 at the N terminus
of helix aC. A second oxygen atom of the 2′ ribose phos-
phate group forms hydrogen bonds to the side chains of
Ser63 and Arg39 and the third oxygen atom hydrogen
bonds to the side chain of Asn62.
The pyrophosphate moiety of the NADPH molecule
interacts with the N termini of helices aB and a1, through
hydrogen bonds with the peptide NH group of residue
Ile41 and the side chain of Thr213. Arg39 is located 3.4 Å
from one of the oxygen atoms of the pyrophosphate
moiety, in part compensating for the negatively charged
oxygen atoms.
Interactions made by the nicotinamide mononucleotide
ribose hydroxyl groups include hydrogen bonds to the side
chains of Tyr178, Lys182 and the peptide oxygen of
Asn114. The nicotinamide ring has the syn conformation
and has its B face oriented towards the inhibitor. It binds
in a pocket formed by the side chains of Ile41, Met162,
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Figure 6
Stereo view of the electron-density map
around NADPH and the inhibitor: 2|Fo|–|Fc|
map contoured at 1s. The phases were from
a refined model of THNR; the NADPH and the
inhibitor were, however, not included in the
refinement at this stage. (Figure generated
with the program MOLSCRIPT [33] and
rendered using Raster3D [34].)
Figure 7
Schematic view of the interactions of NADPH
with THNR. Hydrogen bonds are indicated
with dashed lines.
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Tyr178, Pro208, Thr213, Met215 and Tyr216. Specific
hydrogen bonds position the nicotinamide ring in its
binding site; the carboxamide group forms hydrogen
bonds with the side chain of Thr213 and the peptide
nitrogen of Ile211.
Inhibitor binding
The inhibitor, tricyclazole (Fig. 1b), is enclosed by the
C terminus of strand bF, the bF–a1 loop and the a1
helix, and is completely shielded from the outside solu-
tion. Tricyclazole is bound in a rather large pocket (with 
a volume of 57 Å3), formed by residues Val118, Ser164,
Ile165, Tyr178, Gly210, Met215, Val219, Cys220, Tyr223,
Trp243 and Met283. The N2 and N3 atoms of the
inhibitor form hydrogen bonds with the phenolic hydroxyl
group of Tyr178 and the hydroxyl group of Ser164,
respectively. The inhibitor is stacked between the side
chain of Tyr223 on one side and to a small extent the
nicotinamide ring of NADPH on the other side, with
stacking distances of about 3.5 Å (Fig. 8). The observed
binding mode of tricyclazole at the active site of the
enzyme is consistent with its behavior as a competitive
inhibitor (DJ, unpublished results).
The inhibitor and part of NADPH are buried in the
protein and their binding and release might be controlled
by conformational changes of the enzyme. These changes
could involve helix a1, the connecting loop to a2, and pos-
sibly helix a2, which by shifting their position could open
the way into the active site. This part of the subunit is one
of the most variable in structure when compared to other
similar enzymes, such as 3a,20b-hydroxysteroid dehydro-
genase and dihydropteridine reductase (see below).
Three-dimensional and sequence similarities to other
enzymes
The structural model obtained for THNR clearly identi-
fies the enzyme as a member of the short chain dehydro-
genase/reductase (SDR) family. Members of the SDR
family contain a similar structural fold, this fold consists of
a single domain subunit made up of a central b sheet
(seven or eight b strands), which is flanked on both sides
by a helices. The fold shows a common nucleotide-
binding site characterized by a Gly-X-X-X-Gly-X-Gly fin-
gerprint. A strictly conserved tyrosine residue (Tyr178)
and the largely conserved lysine residue located four
residues downstream (Lys182) [9] are both implicated as
part of the catalytic machinery.
THNR shows amino acid sequence identity (between
20–39%) to several members of the SDR family, including
glucose-1-dehydrogenase [10], 7a-hydroxysteroid dehy-
drogenase [11], corticosteroid 11b-dehydrogenase [12] and
alcohol dehydrogenase [13].
At present the three-dimensional structures of six members
of the SDR family are known, 3a,20b-hydroxysteroid
dehydrogenase [14], 17b-hydroxysteroid dehydrogenase
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Figure 8
(a) Stereo view of the active site of THNR
with the bound inhibitor tricyclazole and
NADPH. (b) The same view as in (a) with the
modeled substrate, trihydroxynaphthalene
(THN) and NADPH. Hydrogen bonds are
shown as dashed lines. (Figure generated
with MOLSCRIPT [33] and rendered with
Raster3D [34].)
[15], carbonyl reductase [16], dihydropteridine reductase
[17] and enoyl acyl carrier protein reductase from both
Brassica napus [18] and Mycoplasma tuberculosis [19]. The
coordinate sets of three members of the SDR family are
available from the PDB database: 3a,20b-hydroxysteroid
dehydrogenase [14]; dihydropteridine reductase [17]; and
enoyl acyl carrier protein reductase [19]. A least squares fit
of the Ca atoms of these enzymes to THNR revealed rms
deviations of 1.5Å, 1.7Å and 1.6 Å using 203, 172 and 211
Ca atoms, respectively. The structure comparison of the
tetramer of THNR with the tetramer of 3a,20b-hydroxys-
teroid dehydrogenase gave rms deviations of 1.9Å using
812 Ca atoms, indicating a high level of structural similarity
even at the quaternary structure level.
The major structural differences between THNR and dihy-
dropteridine reductase are an additional b strand positioned
after bG and a significantly shortened loop, between a1 
and a2, in dihydropteridine reductase. The comparison of
THNR with 3a,20b-hydroxysteroid dehydrogenase reveals
an insertion of 23 residues after residue 268 (THNR num-
bering) and a deletion of residues comprising the region
a1–loop–a2 in the dehydrogenase, resulting in a direct con-
nection from bF to aG (Fig. 4b).
Considerable similarities of the THNR amino acid
sequence to that of the inferred amino acid sequences of
verA in Emericella nidulans [20] and ver-1 in Aspergillus par-
asiticus [21] indicated that both proteins might be struc-
turally and functionally related to THNR [6]. Both the
verA and ver-1 genes code for enzymes which are involved
in aflatoxin biosynthesis and their inferred amino acid
sequences display 66% and 63% sequence identity to that
of THNR, respectively. Stretches with conserved residues
are extensive, the only exception being in the region corre-
sponding to aC, bC and aD (Fig. 9). The differences are
located on the surface of the tetramer, in an area of the
subunit not involved in any of the two interfaces. The
extensive amino acid sequence identity of THNR with the
enzymes encoded by verA and ver-1, suggests that these
enzymes have the same subunit and quaternary structure
as THNR; a similarity which extends beyond the fold and
fingerprint motifs common to short chain dehydrogenases.
This observation implies that nucleotide specificity and
reaction mechanism are shared among the three enzymes.
Both melanin and aflatoxin biosynthesis involve dehydrox-
ylation of polyphenols, where the reductase transfers the
pro-S hydrogen of NADPH to the polyphenol.
Residues responsible for nucleotide specificity
Based on the structure of mouse lung carbonyl reductase
(MLCR) [16], a general pattern responsible for the deter-
mination of nucleotide specificity in the SDR family was
proposed. The determinants comprise two basic residues, a
lysine (or an arginine) and an arginine residue. In THNR,
we observe a variation of this general pattern, the first basic
residue is Arg39 (coincidentally the same sequence
number as the second basic residue in MLCR), found close
to the 2′-phosphate group, but there is no second arginine.
A sequence alignment shows no second arginine close to
the expected position (Fig. 9), instead an alanine is found
at that position in the THNR sequence. This observation
suggests that one basic residue is sufficient to confer
NADPH specificity.
The active site and reaction mechanism
Enzymes of the SDR family contain a highly conserved
Ser-Tyr-Lys triad at the active site and mechanistic 
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Figure 9
Alignment of the amino acid sequence of
THNR [6] with the sequences of enzymes
involved in fungal aflatoxin synthesis, verA
[20] and ver-1 [21], and with mouse lung
carbonyl reductase (MLCR) [35]. Conserved
residues in THNR, verA and ver-1 are
indicated in bold. Residues in MLCR that are
conserved in all four enzymes are also
indicated in bold. The secondary structural
elements of THNR are shown above the
sequence. Residues forming the catalytic triad
are marked by an asterisk.
Res.  1                  20                  40                  60
                                  |<-βA->|   |<----αB---->|<--βB->| |<----αC---
THNR  MAAVTQPRGESKYDAIPGPLGPQSASLEGKVALVTGAGRGIGREMAMELGRRGCKVIVNYANSTESAEEVVAA
Ver-1 MS....................DNHRLDGKVALVTGAGRGIGAAIAVALGERGAKVVVNYAHCRRPRRKWLNR
VerA  MS..................SSDNYRLDGKVALVTGAGRGIGAAIAVALGQPGAKVVVNYANSREAAEKVVDE
MLCR  M......................KLNFSGLRALVTGAGKGIGRDTVKALHASGAKVVAVTRTNSDLVSLAKEC
            80                  100                 120                 140
      -->| |<--βC->|   |<----αD---->|    |<----βD---->|     |<----------αE----
THNR  IKKNGSDAACVKANVGVVEDIVRMFEEAVKIFGKLDIVCSNSGVVSFGHVKDVTPEEFDRVFTINTRGQFFV
Ver-1 SRPMVPMLSQSQADVGDPEATAKLMAETVRHFGYLDIVSSNAGIVSFGHLKDVTPEEFDRVFRVNTRGQFFV
VerA  IKSNAQSAISIQADVGDPDAVTKLMDQAVEHFGYLDIVSSNAFIVSFGHVKDVTPDEFDRVFRVNTRGQFFV
MLCR  PGIEPVCVDLGDWDATEKALGGIGPVDLLVNNAALVIMQPFLE.VTKEAFDRSFSVNLRSVFQVSQM....V
                    160                 180                 200
      ----->|   |<--βE-->|          |<--------αF-------->|  |<--βF-->|    |<--
THNR  AREAYKHLEIGGRLILMGSITGQAKAVPKHAVYSGSKGAIETFARCMAIDMADKKITVNVVAPGGIKTDMYH
Ver-1 AREAYRHMREGGRIILTSSNTACVKGVPKHAVYSGSKGAIDTFVRCMAIDCGDKKITVNAVAPGAIKTDMFL
VerA  AREAYRHLREGGRIILTSSNTASVKGVPRHAVYSGSKGAIDTFVRCLAIDCGDKKITVNAVAPGAIKTDMFL
MLCR  AREMINRGVPGS.IVNVSSMVAHVTF.PNLITYSSTKGAMTMLTKAMAMELGPHKIRVNSVNPTVVLTDMGK
                        *             *   *
        220                 240                  260                 280
      -α1->|        |<---α2--->|         |<---αG--->|        |<-βG->|
THNR  AVCREYIPNGENLSNEEVDEYAAVQW.SPLRRVGLPIDIARVVCFLASNDGGWVTGKVIGIDGGACM
Ver-1 AVSREYIPNGETFTDEQVDECAA..WLSPLNRVGLPVDVARVVSFLASDTAEWVSGKIIGVDGGAFR
VerA  SVSREYIPNGETFTDEQVDECAA..WLSPLNRVGLPVDVARVVSFLASDAAEWISGKIIGVDGGAFR
MLCR  KVSADPEFARKLKERHPLRKFAEVEDVVNSILFLLSDRSASTSGGGILVDAGYLAS
proposals have focused on the central role of these
residues in catalysis [9,14–16]. Common to these proposals
is the suggestion that the invariant tyrosine residue polar-
izes the carbonyl oxygen of the substrate, thereby increas-
ing the electrophilicity of the carbonyl carbon atom and
facilitating hydride transfer from NADPH. After hydride
transfer has occurred, the tyrosine residue donates its phe-
nolic proton to the substrate hydroxyl group. The result-
ing negative charge of the side chain of the tyrosine
residue is stabilized by the lysine residue of the catalytic
triad, either directly through a hydrogen bond [9,14,15] or
through electrostatic interactions [16]. The serine residue
of the triad was suggested to be involved in binding of the
substrate, reaction intermediates and products.
The active site of THNR contains a catalytic triad similar
to other members of this family which suggests that they
share mechanistic features. The position of the substrate,
trihydroxynaphtalene, has been modelled in the active site
of THNR based on the position of the inhibitor (Fig. 8b).
In the enzyme catalyzed reaction, trihydroxynaphtalene
accepts a hydride from NADPH at the C3 position [22].
For hydride transfer to occur, the keto tautomer with a
carbonyl group at the C3 position has to be generated at
the active site. Formation of this less polar species of the
substrate is favored by the predominantly apolar environ-
ment of the active site of THNR.
Conserved residues of the catalytic triad, Ser164 and
Tyr178 are within hydrogen bonding distance of the C3
carbonyl oxygen atom of the keto tautomer of the substrate,
both residues may serve to polarize the carbonyl thereby
facilitating hydride transfer.
The third residue of the triad, Lys182, forms a bifurcated
hydrogen bond to the 2′-hydroxyl and 3′-hydroxyl groups
of the nicotinamide mononucleotide ribose ring, stabiliz-
ing the position and orientation of the nicotinamide ring.
The distance between the hydroxyl oxygen atom of
Tyr178 and the Nε atom of the side chain of Lys182 is
approximately 4.5Å, therefore, a hydrogen bond between
these two residues is unlikely. However, Lys182 might
influence Tyr178 through electrostatic interactions, as
suggested previously [16].
Biological implications
Rice blast disease causes considerable yearly losses in
rice production. This disease is caused by the fungus
Magnaporthe grisea and establishment of the disease
requires biosynthesis of melanin by the fungus. Enzymes
of the melanin biosynthetic pathway are therefore possi-
ble targets for fungicides. The enzyme 1,3,8-trihydroxy-
naphtalene reductase (THNR) catalyzes one step in this
pathway: the NADPH-dependent reduction of 1,3,8-
trihydroxynaphtalene to vermelone. THNR is the site 
of action of the commercial fungicide tricyclazole and
the crystallographic analysis of THNR complexed with
tricyclazole and NAPDPH provides insights into the
structural basis of inhibitor binding.
Determination of the crystal structure of THNR, and a
comparison of enzymes with a similar structure, has
shown THNR to belong to the family of short chain
dehydrogenases. The family of short chain dehydroge-
nases consists of a number of distinct NAD(P)H-depen-
dent enzymes and members of this family are found 
in many metabolic pathways. These enzymes share a
common fold and contain several conserved amino acid
sequence fingerprints involved in nucleotide binding and
catalysis. The identification of THNR, an enzyme
which catalyzes reduction of the keto tautomer of a
phenol, as a member of this family reveals even further
chemical diversity in the already broad spectrum of
chemical reactions catalyzed by this family of enzymes.
Short chain dehydrogenases exhibit differences in their
nucleotide specificities. Based on the crystal structure of
mouse lung carbonyl dehydrogenase [16], it had been
suggested that the specificity for NADPH is conferred
by a sequence motif containing two basic residues which
interact with the 2′ phosphate group of NADPH. The
structure analysis of THNR reveals that only one of
these basic residues is conserved between THNR and
carbonyl reductase and it seems that the second basic
residue is not required to confer specificity for NADPH.
The crystal structure of THNR reported here provides
new insights into coenzyme specificity and inhibitor
binding. Together with the recent structure determina-
tion of scytalone dehydratase, another enzyme in the
pathway of melanin biosynthesis in M. grisea [4], this
structural knowledge might aid in the design of new
inhibitors useful for rice crop protection.
Material and methods
Crystallization
Crystals of THNR complexed with NADPH and tricyclazole were grown
by the hanging-drop vapor diffusion method from buffered PEG 6000
solutions as described previously [23]. The crystals belong to space
group P3121 with cell dimensions a =b=142.6 Å, c=72.9Å. The asym-
metric unit contains two subunits, giving a calculated solvent content of
58.5% based on a Vm value of 3.52 Å3 Da–1 [24].
Data collection and processing
Native and derivative X-ray diffraction data were collected on an Raxis
image plate mounted on a Rigaku rotating anode. Data were processed
and merged using DENZO [25] and CCP4 [26] software. One heavy-
atom derivative was obtained by soaking crystals for 4 h in 5 mM
thimerosal (TMS), and the second derivative after soaking crystals for
1.5 h in 1 mM methylmercuric chloride (MeHgCl). Details of data collec-
tion are given in Table 1.
The structure was solved with multiple isomorphous replacement (MIR)
techniques using the two mercury derivatives. The positions of the
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heavy-metal atoms in the TMS derivative were located with difference
Patterson methods. The difference Patterson map for the MeHgCl
derivative and cross-phased difference Fourier maps, based on single
isomorphous replacement (SIR) phases from the TMS derivative, indi-
cated that the same set of heavy-metal positions was present in the
second derivative. The parameters of the heavy-atom positions were
refined using the program MLPHARE [26]. Both mercury derivatives
shared the same sites and the overall figure of merit was 0.35 (acentric
0.34, centric 0.55).
Map interpretation, model building and refinement
Initial phases were calculated to 3.5 Å resolution and were improved by
solvent flattening and histogram matching with the program DM [27].
The electron-density map calculated from these phases showed the
tetramer boundaries and five b strands in a sheet could be identified. A
trace joining the interpretable regions of electron density was made
using the BONES utility from the program O [28] and used to build a
polyalanine model. Model phases were calculated using the program
SFALL [26] and combined with MIR phases with the program SIGMAA
[26]. The initial non-crystallographic symmetry matrix, obtained from a
self-rotation function calculation, using the program AMoRe [29] and
the heavy-atom positions, was refined using IMP [30]. After several
cycles of twofold averaging, solvent flattening, phase combination and
model building, a model of THNR could be built into the electron-
density map. Based on one of the mercury positions, the biological
amino acid sequence could be fitted to the electron density. During this
model building process, the resolution was gradually extended from 3.5
to 2.8 Å resolution.
Crystallographic refinement was carried out with the program X-PLOR
[31]. During refinement, non-crystallographic symmetry constraints were
applied. Due to the limited resolution of the diffraction data, no attempt
was made to model solvent molecules and an overall anisotropic
B factor was used throughout the refinement procedure, except for the
last cycle. The R factor of the initial model was 46.9% and it was
reduced to 24.4% (Rfree 27.2%) after several cycles of visual rebuilding
and simulated annealing. In the last run, a grouped B factor refinement
was carried out which decreased the conventional and free R factors to
22.3% and 25.4%, respectively. The final refinement and model para-
meters are given in Table 2. The protein model was analyzed with
PROCHECK [32]; accessible surfaces were calculated using the
program AREAIMOL [26].
Accession numbers
The coordinates for 1,3,8-trihydroxynaphthalene reductase have been
submitted to the Brookhaven Protein Data Bank.
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